Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The primary objectives of this study are to evaluate the effect of Obeticholic Acid treatment compared to placebo on 1) histological improvement and 2) liver-related clinical outcomes in patients with non-cirrhotic nonalcoholic steatohepatitis (NASH) with liver fibrosis.
Epistemonikos ID: 9fa3ade50ccdeff2fb651c211bbd74900e58c9ce
First added on: May 12, 2024